![]() |
|
|
1 Department of Pharmacology, University of California Medical Center and Langley Porter Neuropsychiatric Institute, San Francisco, California
Dl-p-Methoxyamphetamine (PMA), unlike d-amphetamine, does not induce stereotyped behaviors and is less effective than d-amphetamine in stimulating psychomotor activity. To investigate the reasons for the different behavior effects caused by PMA and d-amphetamine, a comparison was made between the effects of the two drugs on the release and reuptake of 3H-norepinephrine (NE) and 3H-dopamine (DA) in tissue slices prepared from the cerebral cortex and the corpus striatum of the rat brain. PMA was found to be equipotent to d-amphetamine in causing the release of 3H-NE from the cortex. PMA also increased the release of newly synthesized 3H-NE formed from 3H-DA in this region. However, PMA was less potent than d-amphetamine in causing the release of 3H-DA either taken up from the incubation medium or formed from 3H-tyrosine in the corpus striatum. PMA, as does d-amphetamine, competitively blocks the reuptake of 3H-NE and of 3H-DA into slices prepared from the cortex and corpus striatum, respectively. PMA was 14% as effective as d-amphetamine in blocking 3H-DA uptake in the corpus striatum and was 29% as effective as d-amphetamine in blocking 3H-NE uptake in the cortex. The results suggest that the relatively weak effect of PMA on catecholamine release and reuptake in structures rich in DA-containing neurons may be related to the lack of effect of PMA on locomotor activity and stereotyped behaviors.
Submitted on February 19, 1973